Literature DB >> 16043686

Premature death associated with delirium at 1-year follow-up.

Douglas L Leslie1, Ying Zhang, Theodore R Holford, Sidney T Bogardus, Linda S Leo-Summers, Sharon K Inouye.   

Abstract

BACKGROUND: While previous studies have demonstrated the increased mortality risk associated with delirium, little is known about the mortality time course. The objective of this study is to estimate the fraction of a year of life lost associated with delirium at 1-year follow-up.
METHODS: Hospitalized patients 70 years and older who participated in a previous controlled clinical trial of a delirium prevention intervention at an academic medical center from March 25, 1995, through March 18, 1998, were followed up for 1 year after discharge, and patients who died were identified, along with the date of death. The adjusted number of days survived were estimated using a 2-step regression model approach and compared across patients who developed delirium during hospitalization and those who did not develop delirium.
RESULTS: After adjusting for pertinent covariates (age, sex, functional status, and comorbidity), patients with delirium survived 274 days, compared with 321 days for patients without delirium, representing a difference of 13% of a year (hazard ratio, 1.62; P<.001). Results were confirmed with a separate binomial regression analysis.
CONCLUSIONS: Patients who experienced delirium during hospitalization had a 62% increased risk of mortality and lost an average of 13% of a year of life compared with patients without delirium. Although delirium is an acute condition, it is associated with multiple long-term sequelae that extend beyond the hospital setting, including premature mortality.

Entities:  

Mesh:

Year:  2005        PMID: 16043686     DOI: 10.1001/archinte.165.14.1657

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  52 in total

1.  Apolipoprotein E e4 allele does not increase the risk of early postoperative delirium after major surgery.

Authors:  Fernando José Abelha; Vera Fernandes; Miguela Botelho; Patricia Santos; Alice Santos; J C Machado; Henrique Barros
Journal:  J Anesth       Date:  2012-02-01       Impact factor: 2.078

Review 2.  Delirium in elderly people.

Authors:  Sharon K Inouye; Rudi G J Westendorp; Jane S Saczynski
Journal:  Lancet       Date:  2013-08-28       Impact factor: 79.321

Review 3.  End-of-life considerations in older patients who have lung disease.

Authors:  Renee D Stapleton; J Randall Curtis
Journal:  Clin Chest Med       Date:  2007-12       Impact factor: 2.878

Review 4.  Delirium: where do we stand?

Authors:  Chi-Un Pae; David M Marks; Changsu Han; Ashwin A Patkar; Prakash Masand
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

5.  Delirium superimposed on dementia is associated with prolonged length of stay and poor outcomes in hospitalized older adults.

Authors:  Donna M Fick; Melinda R Steis; Jennifer L Waller; Sharon K Inouye
Journal:  J Hosp Med       Date:  2013-08-19       Impact factor: 2.960

6.  Use of a Geriatric Quality Initiative to Educate Internal Medicine Residents about Delirium and Its Risk Factors.

Authors:  Daniele Olveczky; Melissa L P Mattison; Kenneth J Mukamal
Journal:  J Grad Med Educ       Date:  2013-06

7.  Delirium and other clinical factors with Clostridium difficile infection that predict mortality in hospitalized patients.

Authors:  Laurie R Archbald-Pannone; Timothy L McMurry; Richard L Guerrant; Cirle A Warren
Journal:  Am J Infect Control       Date:  2015-04-24       Impact factor: 2.918

Review 8.  Cardiac surgery, the brain, and inflammation.

Authors:  David A Scott; Lisbeth A Evered; Brendan S Silbert
Journal:  J Extra Corpor Technol       Date:  2014-03

9.  Delirium in hospitalized elderly patients and post-discharge mortality.

Authors:  Danielle Pessoa Lima; Marcelo Eidi Ochiai; Alexandre Bastos Lima; Jose A E Curiati; Jose M Farfel; Wilson Jacob Filho
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

10.  Delirium: underrecognized and undertreated.

Authors:  Chi-Un Pae; David M Marks; Changsu Han; Ashwin A Patkar; Prakash Masand
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.